MYC and neoplasm: AP impedes cellular glycolysis in colorectal cancer cells by obstructing the β-catenin/c-Myc/PTBP1 signaling pathway, thereby inhibiting the activity and expression of tumor-specific PKM2 [58] (Figure 2).